076531420	076531420	CD	B-NP	O
|	|	NN	I-NP	O
MRBGH	MRBGH	NN	I-NP	O
|	|	NN	I-NP	O
02953720	02953720	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7337921	7337921	CD	B-NP	O
|	|	CC	I-NP	O
7/28/2004	7/28/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
ROMI	ROMI	NN	I-NP	B-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/2004	10/9/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/8/2004	8/8/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SKWAREK	SKWAREK	NNP	B-NP	O
,	,	,	O	O
JARVIS	JARVIS	NNP	B-NP	O
V	V	NNP	I-NP	O
277-24-80-3	277-24-80-3	CD	I-NP	O
Angeles	Angeles	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/11/04	2/11/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CANPOS	CANPOS	NN	B-NP	B-protein
,	,	,	O	O
RAFAEL	RAFAEL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/18	3/18	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
50	50	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
CHLORDIAZEPOXIDE	CHLORDIAZEPOXIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/29/04	11/29/04	CD	B-NP	O
by	by	IN	B-PP	O
LANDKAMER	LANDKAMER	NN	B-NP	B-protein
,	,	,	O	O
DAMIAN	DAMIAN	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
75724568	75724568	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Other	Other	NNP	B-NP	O
:	:	:	O	O
throat	throat	IN	B-PP	O
pain	pain	NN	B-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
in	in	RP	B-PRT	O
sitting	sit	VBG	B-VP	O
position	position	NN	B-NP	B-protein
DILANTIN	DILANTIN	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PHENYTOIN	PHENYTOIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
If	If	IN	B-ADJP	I-protein
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
MVI	MVI	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/29/04	11/29/04	CD	B-NP	O
by	by	IN	B-PP	O
BOYARSKY	BOYARSKY	NNP	B-NP	O
,	,	,	O	O
ERICH	ERICH	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39151696	39151696	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LIPITOR	LIPITOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/11/04	2/11/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
RANITIDINE	RANITIDINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
get	get	VB	B-VP	O
blood	blood	NN	B-NP	O
checked	check	VBD	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
INR	INR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Serens	Serens	NNP	I-NP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
dosing	dosing	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
2-3	2-3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/11/04	2/11/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Kimberly	Kimberly	NNP	I-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/29/04	6/29/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Ny	Ny	NNP	B-NP	O
`	`	``	I-NP	O
stan	stan	NN	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
ROMI	ROMI	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
ROMI	ROMI	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
past	past	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
past	past	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
past	past	JJ	I-NP	O
EtOH	EtOH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
seizures	seizure	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
seizure	seizure	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
3vCABG/PCI	3vCABG/PCI	NN	I-NP	O
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
;	;	:	O	O
diastolic	diastolic	JJ	B-NP	O
dysfxn	dysfxn	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
1-2	1-2	CD	B-NP	O
wks	wk	NNS	I-NP	O
of	of	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
and	and	CC	O	O
throat	throat	DT	B-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

Originally	Originally	RB	B-NP	O
s/f	s/f	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
but	but	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
afib	afib	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
RVR	RVR	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	O	O
120s	120s	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
before	before	IN	B-PP	O
test	test	NN	B-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
to	to	TO	B-PP	O
ED	ED	VBN	B-VP	O
where	where	WRB	B-ADVP	O
given	give	VBN	B-PP	O
IV	IV	CD	B-NP	O
lopressor	lopressor	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
with	with	IN	B-PP	O
improved	improve	VBN	B-NP	O
symptoms	symptom	NNS	I-NP	O
after	after	IN	B-PP	O
HR	HR	NN	B-NP	O
control	control	NN	I-NP	O
to	to	TO	B-PP	O
90-100s	90-100	NNS	B-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-NP	O
BP	BP	NN	I-NP	O
135/72	135/72	CD	I-NP	O
HR	HR	NN	I-NP	O
111	111	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
96	96	CD	B-NP	O
RR	RR	NN	I-NP	O
20	20	CD	B-NP	O
SaO2	SaO2	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
;	;	:	O	O
irreg	irreg	NN	B-NP	O
irreg	irreg	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
belly	belly	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
neuro	neuro	NN	I-NP	O
exam	exam	NN	I-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
Neg	Neg	NN	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
39.5	39.5	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
9.37	9.37	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
1.0	1.0	CD	I-NP	O
;	;	:	O	O
EKG	EKG	NN	B-NP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
TWF	TWF	NN	I-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NNP	B-NP	O
L	L	NNP	I-NP	O
;	;	:	O	O
CXR	CXR	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Course	Course	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
with	with	IN	B-PP	O
PAF	PAF	NN	B-NP	B-protein
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
and	and	CC	O	O
throat	throat	NN	B-NP	O
tightness	tightness	NN	I-NP	O
and	and	CC	O	O
re-conversion	re-conversion	NN	B-NP	O
to	to	TO	B-VP	O
afib	afib	VB	I-VP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
ischemia	ischemia	NN	I-NP	O
:	:	:	O	O
Doubted	Doubt	VBN	B-NP	O
ACS	ACS	NN	I-NP	O
but	but	CC	O	O
given	give	VBN	B-NP	O
signif	signif	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
needed	need	VBN	B-VP	O
to	to	TO	B-PP	O
ROMI	ROMI	NN	B-NP	B-protein
--	--	:	O	O
>	>	SYM	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
neg	neg	NN	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
-	-	HYPH	B-NP	O
c/w	c/w	NN	I-NP	O
normal	normal	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
but	but	CC	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	I-VP	O
81mg	81mg	VB	I-VP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	O
:	:	:	O	O
but	but	CC	O	O
increased	increase	VBD	B-VP	O
Atenolol	Atenolol	NN	B-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
from	from	IN	B-PP	O
25mg	25mg	NN	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ACEI	ACEI	NN	B-NP	B-protein
,	,	,	O	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

Held	Held	NNP	B-NP	O
plavix	plavix	NN	I-NP	O
,	,	,	O	O
IIb/IIIa	IIb/IIIa	NNP	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
NSR	NSR	NN	B-NP	B-protein
after	after	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
beta	beta	SYM	B-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
changes	change	NNS	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
studdy	studdy	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
LA	LA	NN	B-NP	O
size	size	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LA	LA	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
;	;	:	O	O
PASP	PASP	NN	B-NP	B-protein
35	35	CD	I-NP	I-protein
+	+	SYM	I-NP	O
RAP	RAP	NN	I-NP	B-protein
and	and	CC	O	O
isolated	isolate	VBN	B-NP	O
HK	HK	NN	I-NP	O
in	in	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
septum	septum	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
HK	HK	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
mid-septum	mid-septum	NN	B-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
and	and	CC	O	O
D-dimer	D-dimer	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
suggesting	suggest	VBG	B-VP	O
against	against	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
refused	refuse	VBD	B-VP	O
lovenox	lovenox	NN	B-NP	O
shots	shot	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
CVA	CVA	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
on	on	IN	B-PP	O
10/13	10/13	CD	B-NP	O
am	am	NN	I-NP	O
by	by	IN	B-PP	O
Spe	Spe	NNP	B-NP	O
Health	Health	NNP	I-NP	O
at	at	IN	B-PP	O
RAH	RAH	NNP	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Pump	Pump	NN	I-NP	O
:	:	:	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
but	but	CC	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dyxfxn.Echo	dyxfxn.Echo	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
sign	sign	VB	I-VP	O
ificantly	ificantly	RB	I-VP	O
altered	alter	VBN	I-VP	O
from	from	IN	B-PP	O
1999	1999	CD	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
suppl	suppl	NN	B-NP	O
O2	O2	NN	I-NP	O
and	and	CC	O	O
DOE	DOE	NN	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
cardiac-related	cardiac-related	JJ	I-ADJP	O
.	.	.	O	O

Workup	Workup	NN	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
stable	stable	JJ	B-NP	O
Cr	Cr	NN	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Dilantin	Dilantin	NN	B-NP	O
for	for	IN	B-PP	O
sz	sz	NN	B-NP	O
d/o	d/o	NN	I-NP	O
.	.	.	O	O

Dilantin	Dilantin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Ranitidine	Ranitidine	NN	B-NP	O
for	for	IN	B-PP	O
PUD	PUD	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Chlordiazepoxide	Chlordiazepoxide	NN	B-NP	B-protein
per	per	IN	B-PP	I-protein
home	home	NN	B-NP	I-protein
dosing	dosing	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
Pt	Pt	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Newthic	Newthic	JJ	B-NP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
on	on	IN	B-PP	O
10/13	10/13	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
coumadin	coumadin	NN	B-NP	O
adjustment	adjustment	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Plunk	Plunk	NNP	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	O	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Have	Have	VB	B-VP	O
INR	INR	NN	B-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
10/13	10/13	CD	B-NP	O
am	am	NN	I-NP	O
for	for	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
adjustment	adjustment	NN	I-NP	O
by	by	IN	B-PP	O
Gardman	Gardman	NNP	B-NP	B-protein
Vero	Vero	NNP	I-NP	I-protein
Men	Men	NNP	I-NP	I-protein
Medical	Medical	NNP	I-NP	I-protein
Center	Center	NNP	I-NP	I-protein
clinic	clinic	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
goal	goal	NN	I-NP	I-protein
2-3	2-3	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GEISLER	GEISLER	NNP	B-NP	O
,	,	,	O	O
HUBERT	HUBERT	NNP	B-NP	O
BILLY	BILLY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FR5	FR5	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/11/04	2/11/04	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

